Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy

Author(s): William S.M. Wold, Karoly Toth.

Journal Name: Current Gene Therapy

Volume 13 , Issue 6 , 2013

Become EABM
Become Reviewer

Abstract:

Adenovirus vectors are the most commonly employed vector for cancer gene therapy. They are also used for gene therapy and as vaccines to express foreign antigens. Adenovirus vectors can be replication-defective; certain essential viral genes are deleted and replaced by a cassette that expresses a foreign therapeutic gene. Such vectors are used for gene therapy, as vaccines, and for cancer therapy. Replication-competent (oncolytic) vectors are employed for cancer gene therapy. Oncolytic vectors are engineered to replicate preferentially in cancer cells and to destroy cancer cells through the natural process of lytic virus replication. Many clinical trials indicate that replication-defective and replication-competent adenovirus vectors are safe and have therapeutic activity.

Keywords: Adenovirus, replication-defective, oncolytic, cancer gene therapy, vaccines, safe and well-tolerated.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 13
ISSUE: 6
Year: 2013
Page: [421 - 433]
Pages: 13
DOI: 10.2174/1566523213666131125095046
Price: $58

Article Metrics

PDF: 73